Hogarth P M, Basten A, Prichard-Briscoe H, Henning M H, Sutton V R, McKenzie I F
J Immunol. 1985 Sep;135(3):1632-6.
The expression of Qa-2 on functional lymphocytes was investigated in vitro and in vivo by using a monoclonal anti-Qa-2 antibody. In vitro treatment of T cells with antibody and complement demonstrated that T cells mediating help or delayed-type hypersensitivity for anti-SRBC responses were Qa-2+. In addition, cytotoxic T cells and either their precursors or cells involved in their generation were Qa-2+, as were anti-HGG suppressor T cells. Panning techniques were also used to show that secondary suppressor T cells were Qa-2+ and that there may be heterogeneity in suppressor T cells defined by Qa-2 expression. In vivo treatment of mice with anti-Qa-2 resulted in decrease in immune responsiveness seen by i) prolongation of skin grafts with either H-2D or I-A differences, ii) suppression of delayed-type hypersensitivity, and iii) inhibition of T cell-mediated suppression. Finally, IgG, but not IgM, anti-body-forming cells were Qa-2+.
利用单克隆抗Qa-2抗体在体外和体内研究了功能性淋巴细胞上Qa-2的表达。用抗体和补体在体外处理T细胞表明,介导对抗SRBC反应的辅助或迟发型超敏反应的T细胞是Qa-2阳性。此外,细胞毒性T细胞及其前体或参与其产生的细胞是Qa-2阳性,抗HGG抑制性T细胞也是如此。淘选技术还用于表明二级抑制性T细胞是Qa-2阳性,并且由Qa-2表达定义的抑制性T细胞可能存在异质性。用抗Qa-2对小鼠进行体内处理导致免疫反应性降低,表现为:i)具有H-2D或I-A差异的皮肤移植物存活时间延长,ii)迟发型超敏反应受到抑制,iii)T细胞介导的抑制作用受到抑制。最后,IgG抗体形成细胞是Qa-2阳性,而IgM抗体形成细胞不是。